BioStem Technologies (OTCMKTS:BSEM) Issues Earnings Results

BioStem Technologies (OTCMKTS:BSEM) issued its quarterly earnings data on Monday. The company reported -0.14 earnings per share for the quarter, reports. The firm had revenue of 11.44 million during the quarter, compared to analyst estimates of 11.40 million.

BioStem Technologies Price Performance

OTCMKTS BSEM traded up 0.66 during trading hours on Wednesday, hitting 13.89. 23,500 shares of the company were exchanged, compared to its average volume of 29,014. The company’s 50 day simple moving average is 8.64. BioStem Technologies has a 52-week low of 1.20 and a 52-week high of 15.50.

BioStem Technologies Company Profile

BioStem Technologies, Inc, a life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services. It develops various biologic stem cell based alternative products, as a treatment for ailments, such as joint pain, tendon and ligament injuries, neurodegenerative, and autoimmune diseases.